Elaborating on the modernisation roadmap for all three armed forces, General Chauhan said the nature of warfare is undergoing ...

The Ibrox side are closing in on four deals and two of them could even be done in time to face Abereen this weekend ...

The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

Fort Hill’s Casey Martz (60) bolts to his left after centering the ball to quarterback Noah House during the Sentinels’ home ...

In the second part of this series, the focus shifts to partners — external forces whose alignment, trust and intent decide ...

The 2026 NFL Draft order is set for the top 18 picks. With the postseason on the way and lots of coaching changes, here's our ...

Analyze the CGDV ETF: strategy vs. “dividend value” label, returns vs. SPY, earnings growth, valuation risk, overlap, and low ...

OpenAI just released a report about healthcare drawn from anonymized chatbot conversations. The title could double as one of ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

Enhanced technology and human expertise drive 49% increase in vetted remote job postings to Virtual Vocations database. The 49% increase in fully remote job postings we saw in 2025 is a direct result ...

The gap between the Astros' ace, Hunter Brown, and the rest of their rotation narrows with the addition of Imai.

Investing.com -- Q32 Bio Inc (NASDAQ:QTTB) stock surged 94% in premarket trading Monday after the clinical-stage biotechnology company announced the sale of its Phase 2 complement inhibitor, ADX-097, ...